Xponance, Inc. Exact Sciences Corp Transaction History

Xponance, Inc.

$9.68 Billion
Q2 2024

A detailed history of Xponance, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Xponance, Inc. holds 21,576 shares of EXAS stock, worth $1.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

21,576

Previous 20,777 3.85%

Holding current value

$1.52 Million

Previous $1.43 Million 36.47%

% of portfolio

0.01%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $33,022 - $59,333	799 Added 3.85%	21,576 $911,000
Q1 2024 May 13, 2024	BUY	$56.27 - $73.77 $471,092 - $617,602	8,372 Added 67.49%	20,777 $1.43 Million
Q4 2023 Jan 31, 2024	SELL	$59.06 - $75.72 $39,452 - $50,580	-668 Reduced 5.11%	12,405 $917,000
Q3 2023 Oct 23, 2023	BUY	$65.94 - $99.04 $15,495 - $23,274	235 Added 1.83%	13,073 $891,000
Q2 2023 Jul 13, 2023	BUY	$62.68 - $95.05 $207,032 - $313,950	3,303 Added 34.64%	12,838 $1.21 Million
Q1 2023 Apr 17, 2023	BUY	$47.19 - $70.77 $1,557 - $2,335	33 Added 0.35%	9,535 $646,000
Q4 2022 Jan 23, 2023	BUY	$30.35 - $53.15 $83,159 - $145,631	2,740 Added 40.52%	9,502 $0
Q3 2022 Oct 24, 2022	BUY	$31.97 - $49.37 $5,658 - $8,738	177 Added 2.69%	6,762 $220,000
Q2 2022 Aug 02, 2022	SELL	$35.61 - $76.23 $424,720 - $909,195	-11,927 Reduced 64.43%	6,585 $259,000
Q1 2022 Apr 20, 2022	BUY	$57.56 - $82.54 $19,512 - $27,981	339 Added 1.87%	18,512 $1.29 Million
Q4 2021 Jan 31, 2022	BUY	$72.5 - $100.68 $435 - $604	6 Added 0.03%	18,173 $1.41 Million
Q3 2021 Nov 05, 2021	SELL	$90.24 - $124.05 $38,352 - $52,721	-425 Reduced 2.29%	18,167 $1.73 Million
Q2 2021 Aug 12, 2021	BUY	$93.66 - $139.27 $478,602 - $711,669	5,110 Added 37.9%	18,592 $2.31 Million
Q1 2021 May 10, 2021	BUY	$116.57 - $155.01 $17,485 - $23,251	150 Added 1.13%	13,482 $1.78 Million
Q4 2020 Feb 11, 2021	SELL	$99.61 - $142.12 $16,236 - $23,165	-163 Reduced 1.21%	13,332 $1.77 Million
Q3 2020 Oct 26, 2020	BUY	$72.92 - $102.01 $4,156 - $5,814	57 Added 0.42%	13,495 $1.38 Million
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $749,168 - $1.25 Million	13,438 New	13,438 $1.17 Million

Others Institutions Holding EXAS

# of Institutions

637

Shares Held

166M

Call Options Held

1.93M

Put Options Held

1.23M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $12.5B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account